Whole blood assay and visceral leishmaniasis: Challenges and promises

Immunobiology

Volumn 219, Issue 4, 2014, Pages 323-328

  Singh, Om Prakash ^a   Sundar, Shyam ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

IGRA; LST; SLA; Visceral leishmaniasis; Whole blood assay

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; PARASITE ANTIGEN;

ANTIGEN PRESENTING CELL; BIOASSAY; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LEISHMANIN SKIN TEST; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TH1 CELL; VISCERAL LEISHMANIASIS; WHOLE BLOOD ASSAY; ANIMAL; BLOOD CELL; BLOOD EXAMINATION; IMMUNOLOGY; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; PROCEDURES; TRENDS;

ANIMALS; ANTIGENS, PROTOZOAN; BLOOD CELLS; HEMATOLOGIC TESTS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LEUKOCYTES, MONONUCLEAR; RESEARCH DESIGN;

EID: 84895494597     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.01.005     Document Type: Review

References (73)

1. Aabye M.G., Ravn P., Johansen I.S., Eugen-Olsen J., Ruhwald M. Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens. Clin. Vaccine Immunol. 2011, 18(7).
2. Alimohammadian M.H., Jones S.L., Darabi H., et al. Assessment of interferon-γ levels and leishmania skin test results in person recovered for leishmaniasis. Am. J. Trop. Med. Hyg. 2012, 87(1):70-75.
3. Alvar J., Velez I., Bern C., et al. Leishmaniasis world wide and global estimates of its incidence. PLoS One 2012, 7:pe35671.
4. Anderson C.F., Stumhofer J.S., Hunter C.A., Sacks D. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J. Immunol. 2009, 183:4619-4627.
5. Ansari N.A., Kumar R., Gautam S., et al. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J. Immunol. 2012, 186:3977-3985.
6. Bacellar O., Brodskyn C., Guerreiro J., et al. Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J. Infect. Dis. 1996, 173:1515-1518.
7. Badaro R., Jones T.C., Carvalho E.M., et al. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 1986, 154:1003-1011.
8. Bart O., Gidwani K., Picado A., et al. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high endemic foci in India and Nepal: a prospective study. PLoS Negl. Trop. Dis. 2011, 5(10):e1284. 10.1371/journal.pntd.0001284.
9. Bhattacharjee S., Gupta G., Bhattacharya P., et al. Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide. Indian J. Exp. Biol. 2009, 47:489-497.
10. Black G.F., Dockrell H.M., Crampin A.C., et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in Northern Malawi. J. Infect. Dis. 2001, 184:322-329.
11. Black G.F., Fine P.E.M., Warndorff D.K., et al. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int. J. Tuberc. Lung Dis. 2001, 5.
12. Black G.F., Weir R.E., Floyd S., et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002, 359:1393-1401.
13. Butera O., Chiacchio T., Carrara S., et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect. Dis. 2009, 21(9):182.
14. Caldas A., Favali C., Aquino D., et al. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect. Dis. 2005, 5:113.
15. Carvalho E.M., Bacellar O., Barral A., Badaro R., Johnson W.D. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J. Clin. Invest. 1989, 83:860-864.
16. Carvalho E.M., Bacellar O., Brownell C., et al. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 1994, 152:5949-5956.
17. Carvalho E.M., Badaro R., Reed S.G., Jones T.C., Johnson W.D. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 1985, 76:2066-2069.
18. Cattamanchi A., Ssewenyana I., Davis J.L., Huang L., Worodria W., Boon Sd, et al. Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect. Dis. 2010, 10.1186/1471-2334-10-75.
19. Chapey E., Wallon M., Debize G., Rabilloud M., Peyron F. Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J. Clin. Microbiol. 2010, 48(1):41-45.
20. Chappuis F., Sundar S., Hailu A., et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat. Rev. Microbiol. 2007, 5:873-882.
21. Clements M.F., Gidwani K., Kumar R., et al. Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva. Am. J. Trop. Med. Hyg. 2010, 82:801-807.
22. De Groote D., Zangerle P., Gevaert Y., et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992, 4(MAY 3)):239-248.
23. Dheda K., Lalvani A., Miller R.F., Scott G., Booth H., Johnson M.A., et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005, 19:2038-2041.
24. Diel R., Goletti D., Ferrara G., et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 2011, 37(January (1)):88-99. (Epub 2010 Oct 28).
25. Duthie M.S., Goto W., Ireton G.C., Reece S.T., Sampaio L.H., Grassi A.B., et al. Antigen-specific T-cell responses of leprosy patients. Clin. Vaccine Immunol. 2008, 15(11):1659-1665.
26. Fiavey N.P., Frankenburg S. Appraisal of the total blood lymphocyte proliferation assay as a diagnostic tool in screening for tuberculosis. J. Med. Microbiol. 1992, 37(October (4)):283-285.
27. Fröhlich A., Marsland B.J., Sonderegger I., et al. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 2007, 109(5):2023-2031.
28. Gautam S., Kumar R., Maurya R., et al. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J. Infect. Dis. 2011, 204:1134-1137.
29. Ghalib H.W., Piuvezam M.R., Skeiky Y.A., et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 1993, 92:324-329.
30. Ghalib H.W., Whittle J.A., Kubin M., et al. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J. Immunol. 1995, 154:4623-4629.
31. Gidwani K., Jones S., Kumar R., Boelaert M., Sundar S. Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study. PLoS Negl. Trop. Dis. 2011, 5:e1042.
32. Gidwani K., Kumar R., Rai M., Sundar S. Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India. Am. J. Trop. Med. Hyg. 2009, 80:345-346.
33. Gidwani K., Rai M., Chakravarty J., Boelaert M., Sundar S. Evaluation of leishmanin skin test in Indian visceral leishmaniasis. Am. J. Trop. Med. Hyg. 2009, 80:566-567.
34. Gupta G., Majumdar S., Adhikari A., et al. Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning Leishmania donovani-infected mice. Med. Microbiol. Immunol. 2011, 200(4):241-253.
35. Hailu A., Gramiccia M., Kager P.A. Visceral leishmaniasis in Aba-Roba, South-Western Ethiopia: prevalence and incidence of active and subclinical infections. Ann. Trop. Med. Parasitol. 2009, 103:659-670.
36. Haldar J.P., Ghose S., Saha K.C., Ghose A.C. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect. Immun. 1983, 42:702-707.
37. Ho J.L., Badaro R., Schwartz A., et al. Diminished in vitro production of interleukin-1 and tumor necrosis factor-alpha during acute visceral leishmaniasis and recovery after therapy. J. Infect. Dis. 1992, 165:1094-1102.
38. Jeronimo S.M., Oliveira R.M., Mackay S., et al. An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:386-388.
39. Jeronimo S.M., Teixeira M.J., Sousa A., et al. Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up. Clin. Infect. Dis. 2000, 30:608-609.
40. Junge U., Hoekstra J., Deinhardt F. Altered antigenicity of cultured mononucleosis lymphocytes. Lancet 1970, 2(July (7665)):217.
41. Kaneene J., Johnson D., Anderson R., Muscoplat C. Comparison of sensitivity and specificity of purified lymphocyte and whole-blood in vitro lymphocyte stimulation assays in detection of Brucella abortus infection in cattle. J. Clin. Microbiol. 1978, 8(October (4)):396-401.
42. Kabeer B.S.A., Sikhamani R., Swaminathan S., Perumal V., Paramasivam P., Raja A. Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One 2009, e5718.
43. Kedzierski L., Curtis J.M., Doherty P.C., Handman E., Kedzierska K. Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites. Eur. J. Immunol. 2008, 38:3090-3100.
44. Koskela P., Herva E. Cell-mediated immunity against Francisella tularensis after natural infection. Scand. J. Infect. Dis. 1980, 12(4):281-287.
45. Kobashi Y., Obase Y., Fukuda M., Yoshida K., Miyashita N., Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin. Infect. Dis. 2006, 43:1540-1546.
46. Leroux M., Schindler L., Braun R., et al. A whole-blood lymphoproliferation assay for measuring cellular immunity against herpes viruses. J. Immunol. Methods 1985, 79(MAY 2)).
47. Leyten E.M., Lin M.Y., Franken K.L., et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microb. Infect. 2006, 8(8):2052-2060.
48. Mazurek G., Jereb J., Vernon A., et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm. Rep. 2010, 59(June (RR-5)):1-25.
49. Mori T., Sakatani M., Yamagishi F., Takashima T., Kawabe Y., Nagao K., et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am. J. Respir. Crit. Care Med. 2004, 170:59-64.
50. Murray H.W., Flanders K.C., Donaldson D.D., et al. Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect. Immun. 2005, 73:3903-3911.
51. Nateghi Rostami M., Keshavarz H., Edalat R., et al. CD8+ T cells as a source of IFN-gamma production in human cutaneous leishmaniasis. PLoS Negl. Trop. Dis. 2010, 4:e845.
52. New WHO recommendations on use of commercial TB interferon-γ release assay (IGRAs) in low and middle income countries (ed. WHO), http://www.who.int/tb/features_archive/igra_policy%2024oct/en/index.html.
53. Nylen S., Maurya R., Eidsmo L., et al. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J. Exp. Med. 2007, 204:805-817.
54. Pai M., Zwerling A., Menzies D. Systematic Review: T-Cell-based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update. Ann. Intern. Med. 2008, 149(3):177-184.
55. Paty D., Hughes D. Lymphocyte transformation using whole blood cultures: an analysis of responses. J. Immunol. Methods 1972, 2(NOVEMBER 1)):99-114.
56. Pauly J., Sokal J., Han T. Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes. J. Lab. Clin. Med. 1973, 82(September (3)):500-512.
57. Peruhype-Magalhaes V., Martins-Filho O.A., Prata A., et al. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin. Exp. Immunol. 2006, 146:124-132.
58. Petrovsky N., Harrison L. Cytokine-based human whole blood assay for the detection of antigen-reactive T cells. J. Immunol. Methods 1995, 186:37-46.
59. Rothel, J.S., Wild, S., Cosgriff, A., 2004. Diagnostic assay for measuring a T cell mediated immune response. US7608393.
60. Sacks D.L., Lal S.L., Shrivastava S.N., Blackwell J., Neva F.A. An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 1987, 138:908-913.
61. Saha S., Mondal S., Ravindran R., et al. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J. Immunol. 2007, 179:5592-5603.
62. Satti I., el Hassan A., Khalil el T.A., Akuffo H. The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:565-567.
63. Schnorr D., Muniz A.C., Passos S., et al. IFN-γ production to Leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infection. PLoS Negl. Trop. Dis. 2012, 6(12):e1947. (Epub 2012 Dec 20). 10.1371/journal.pntd.0001947.
64. Singh O.P., Gidwani K., Kumar R., et al. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin. Vaccine Immunol. 2012, 19(6):961-966.
65. Singh O.P., Stober C.B., Singh A.K., Blackwell J.M., Sundar S. Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis. PLoS Negl. Trop. Dis. 2012, 6:e1874.
66. Stenger S., Modlin R. Control of Mycobacterium tuberculosis through mammalian toll-like receptors. Curr. Opin. Immunol. 1999, 14(August (4)):452-457.
67. Sudarshan M., Weirather J.L., Wilson M.E., Sundar S. Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis. J. Antimicrob. Chemother. 2011, 66:1751-1755.
68. Turgay N.B.I., Toz S.O., Ozbel Y., Jones S.L. QuantiFERON - leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection. Am. J. Trop. Med. Hyg. 2010, 822-824.
69. Vitale G., Reina G., Mansueto S., et al. The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients. Clin. Exp. Immunol. 1992, 90:219-222.
70. Weir R., Butlin C., Neupane K., Failbus S., Dockrell H. Use of a whole blood assay to monitor the immune response to mycobacterial antigens in leprosy patients: a predictor for type 1 reaction onset?. Lepr. Rev. 1998, 69(September (3)):279-299.
71. Weir R., Morgan A., Britton W., Butlin C., Dockrell H. Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J. Immunol. Methods 1994, 176(NOVEMBER 1)):93-101.
72. Weir R.E., Brennan P., Butlin C., Dockrell H. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects. Clin. Exp. Immunol. 1999, 116(MAY 2)).
73. Wilhelm P., Wiede F., Meissner A., et al. TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice. Microbes Infect. 2005, 15:1461-1468.